Bio-Path Holdings, Inc.
BPTH· OTC
BPTHBio-Path Holdings, Inc.
Filed May 20, 2026 · 10-Q · 50 days after period end · 0001663577-26-000156
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$270.00K | -$2.85M | -$3.16M | -$5.27M |
| EPS Diluted | -$0.03 | -$0.40 | -$4.88 | -$13.25 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 20, 2026 · 50 d after period end
